Newspaper Publication- Q4 and FY 26 Financial Results
MOREPENLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Morepen Laboratories published its audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026 in newspapers (Financial Express and Jansatta) on May 27, 2026. The Board approved these results on May 26, 2026. Consolidated full-year Total Income was Rs. 5,122.68 Lakhs vs Rs. 4,966.31 Lakhs previous year. Net Profit after tax grew to Rs. 2,295.67 Lakhs vs Rs. 1,867.09 Lakhs, representing approximately 23% YoY growth. Basic EPS stood at Rs. 12.62 (annualised) for FY26 vs Rs. 10.26 in FY25. Standalone Net Profit was Rs. 2,239.39 Lakhs vs Rs. 1,814.58 Lakhs. The results were reviewed by the Audit Committee before Board approval. The filing also notes a special window for dematerialisation of physical shares purchased before April 1, 2019, available until February 4, 2027.
The financial results show healthy YoY growth in both revenue and profitability. Net profit growth of ~23% is positive for shareholders. However, this is a routine compliance filing and results were likely already priced in.